InterCure Ltd. (INCR.TA)

1,096.00 -18.00 (-1.62%) At close: 05:24PM IDT

InterCure Ltd.

85 Medinat ha-Yehudim Street
Herzliya 4676670
Israel
972 7 746 05012
https://www.intercure.co

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 270

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Alexander Rabinovich	CEO & Director	728k	N/A	1971
Mr. Amos Cohen	Chief Financial Officer	1.13M	N/A	1979
Einat Zehavi	Vice President of Sales	859k	N/A	N/A

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in ILA.

Description

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. It operates through Cannabis and Biomed segments. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

Corporate Governance

InterCure Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.